{"id":139998,"date":"2022-06-15T11:20:51","date_gmt":"2022-06-15T11:20:51","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/faq\/"},"modified":"2025-10-06T08:58:41","modified_gmt":"2025-10-06T08:58:41","slug":"faq","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/en-gb\/faq\/","title":{"rendered":"FAQ"},"content":{"rendered":"

[vc_row row_height_percent=”100″ back_color=”color-138503″ back_image=”112255″ back_repeat=”no-repeat” back_attachment=”scroll” back_position=”center center” parallax=”yes” overlay_alpha=”50″ gutter_size=”4″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ enable_bottom_divider=”default” bottom_divider_inv=”tilt” shape_bottom_invert=”yes” shape_bottom_h_use_pixel=”” shape_bottom_height=”100″ shape_bottom_color=”color-xsdn” shape_bottom_opacity=”100″ shape_bottom_index=”0″ medium_visibility=”yes” mobile_visibility=”yes” row_name=”iphone” el_class=”gradient” uncode_shortcode_id=”111541″ back_color_type=”uncode-palette” shape_bottom_color_type=”uncode-palette”][vc_column column_width_use_pixel=”yes” position_vertical=”middle” align_horizontal=”align_center” gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”7″ align_mobile=”align_center_mobile” mobile_width=”0″ css_animation=”bottom-t-top” animation_delay=”200″ width=”1\/1″ uncode_shortcode_id=”276875″ column_width_pixel=”1000″][vc_custom_heading text_color=”color-681992″ heading_semantic=”h1″ text_font=”font-514338″ text_weight=”300″ sub_lead=”yes” sub_reduced=”yes” uncode_shortcode_id=”140228″ text_color_type=”uncode-palette”]Frequently Asked Questions<\/span>[\/vc_custom_heading][vc_custom_heading text_color=”color-196438″ heading_semantic=”h1″ text_font=”font-195745″ text_size=”” text_weight=”600″ sub_lead=”yes” sub_reduced=”yes” uncode_shortcode_id=”114728″ text_color_type=”uncode-palette”]YOUR QUESTIONS, ANSWERED.[\/vc_custom_heading][vc_empty_space empty_h=”1″][vc_empty_space empty_h=”2″][\/vc_column][\/vc_row][vc_row row_height_percent=”100″ back_color=”color-138503″ back_image=”112249″ back_repeat=”no-repeat” back_attachment=”fixed” back_position=”center bottom” overlay_alpha=”50″ gutter_size=”4″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ enable_bottom_divider=”default” bottom_divider_inv=”tilt” shape_bottom_invert=”yes” shape_bottom_h_use_pixel=”” shape_bottom_height=”100″ shape_bottom_color=”color-xsdn” shape_bottom_opacity=”100″ shape_bottom_index=”0″ desktop_visibility=”yes” mobile_visibility=”yes” row_name=”iphone” el_class=”gradient” uncode_shortcode_id=”114217″ back_color_type=”uncode-palette” shape_bottom_color_type=”uncode-palette”][vc_column column_width_use_pixel=”yes” position_vertical=”middle” align_horizontal=”align_center” gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”7″ align_mobile=”align_center_mobile” mobile_width=”0″ css_animation=”bottom-t-top” animation_delay=”200″ width=”1\/1″ uncode_shortcode_id=”276875″ column_width_pixel=”1000″][vc_empty_space empty_h=”3″][vc_custom_heading text_color=”color-681992″ heading_semantic=”h1″ text_font=”font-514338″ text_weight=”300″ sub_lead=”yes” sub_reduced=”yes” uncode_shortcode_id=”166716″ text_color_type=”uncode-palette”]Frequently Asked Questions<\/span>[\/vc_custom_heading][vc_custom_heading text_color=”color-196438″ heading_semantic=”h1″ text_font=”font-195745″ text_size=”” text_weight=”600″ sub_lead=”yes” sub_reduced=”yes” uncode_shortcode_id=”105352″ text_color_type=”uncode-palette”]YOUR QUESTIONS, ANSWERED.[\/vc_custom_heading][vc_empty_space empty_h=”1″][vc_empty_space empty_h=”5″][\/vc_column][\/vc_row][vc_row row_height_percent=”100″ back_color=”color-138503″ back_image=”112248″ back_attachment=”scroll” back_position=”center center” overlay_alpha=”50″ gutter_size=”4″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ enable_bottom_divider=”default” bottom_divider_inv=”tilt” shape_bottom_invert=”yes” shape_bottom_h_use_pixel=”” shape_bottom_height=”100″ shape_bottom_color=”color-xsdn” shape_bottom_opacity=”100″ shape_bottom_index=”0″ desktop_visibility=”yes” medium_visibility=”yes” row_name=”iphone” el_class=”gradient” uncode_shortcode_id=”308018″ back_color_type=”uncode-palette” shape_bottom_color_type=”uncode-palette”][vc_column column_width_use_pixel=”yes” position_vertical=”middle” align_horizontal=”align_center” gutter_size=”3″ style=”dark” overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”7″ align_mobile=”align_center_mobile” mobile_width=”0″ css_animation=”bottom-t-top” animation_delay=”200″ width=”1\/1″ uncode_shortcode_id=”276875″ column_width_pixel=”1000″][vc_empty_space empty_h=”2″][vc_custom_heading text_color=”color-681992″ heading_semantic=”h1″ text_font=”font-514338″ text_size=”h4″ text_weight=”300″ sub_lead=”yes” sub_reduced=”yes” uncode_shortcode_id=”134194″ text_color_type=”uncode-palette”]Frequently Asked Questions<\/span>[\/vc_custom_heading][vc_custom_heading text_color=”color-196438″ heading_semantic=”h1″ text_font=”font-195745″ text_weight=”600″ sub_lead=”yes” sub_reduced=”yes” uncode_shortcode_id=”420235″ text_color_type=”uncode-palette”]YOUR QUESTIONS, ANSWERED.[\/vc_custom_heading][vc_empty_space empty_h=”5″][\/vc_column][\/vc_row][vc_row row_height_percent=”100″ override_padding=”yes” h_padding=”2″ top_padding=”7″ bottom_padding=”7″ back_color=”color-xsdn” overlay_alpha=”50″ gutter_size=”0″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ top_divider=”step_1_2″ desktop_visibility=”yes” mobile_visibility=”yes” changer_back_color=”yes” uncode_shortcode_id=”120331″ back_color_type=”uncode-palette” row_name=”questions”][vc_column column_width_percent=”100″ gutter_size=”5″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”166430″][vc_row_inner limit_content=””][vc_column_inner width=”1\/3″][vc_custom_heading text_color=”color-681992″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”384218″ text_color_type=”uncode-palette”]General questions[\/vc_custom_heading][vc_empty_space empty_h=”2″][\/vc_column_inner][vc_column_inner width=”2\/3″][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”999729″ subheading=”Your health will be monitored continuously throughout StrateGIST 3 Trial. Even if you do not directly benefit from participating in the trial, any information collected may help researchers learn more about the study drug IDRX-42 and about treating other adults with GIST in the future.”]What are the benefits of participating in StrateGIST 3?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”146860″ subheading=”As with all medicines, there is a risk for side-effects from the study drugs. However, your safety is our top priority. Your health will be closely monitored during the entire study. A special group of experts called the Data Monitoring Committee will also review data throughout the entire trial to ensure that all participants are kept safe.”]Are their risks to participating in the trial?[\/vc_custom_heading][vc_custom_heading 1=”biopharmaceutical” 2=”company” 3=”IDRx,” 4=”Inc.” 5=”is” 6=”sponsoring” 7=”the” 8=”clinical” 9=”trial.” 10=”They” 11=”will” 12=”pay” 13=”the” 14=”study” 15=”doctor” 16=”and” 17=”site” 18=”staff” 19=”to” 20=”run” 21=”this” 22=”trial.” 23=”To” 24=”learn” 25=”more” 26=”about” 27=”IDRx,” 28=”visit” 29=”” 30=”href=““https:\/\/www.idrx.com““>www.idrx.com” 31=”.“” heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”148716″]Who is sponsoring the StrateGIST 3 clinical trial?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=”203685″ css=”.vc_custom_1731516055759{margin-top: 10px !important;}”]The biopharmaceutical company IDRx, Inc. is sponsoring the StrateGIST 3 clinical trial. They will pay the study doctors and site staff to run the trial. To learn more about IDRx, visit <\/span>www.idrx.com<\/a>.[\/vc_column_text][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”150124″ subheading=”The study treatment, site visits and study-related tests will be paid for by the clinical trial sponsor, IDRx, Inc. and will not cost you anything. You will be reimbursed for reasonable study visit-related travel expenses.”]Will it cost me anything to be in the trial?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”430406″ subheading=”Participation in a clinical trial is voluntary. If you decide to join and then change your mind, you can leave the trial at any time. Leaving the trial will not affect your regular medical care.”]What if I decide to join the trial and then change my mind?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=””][vc_column_inner width=”1\/3″][vc_custom_heading text_color=”color-681992″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”115706″ text_color_type=”uncode-palette”]Study drug questions[\/vc_custom_heading][vc_empty_space empty_h=”2″][\/vc_column_inner][vc_column_inner width=”2\/3″][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”138330″ subheading=”GIST is frequently caused by changes, or mutations, in a gene for a normal cell protein called KIT. These mutations lead to over-activation of KIT \u2013 like a switch stuck in the on position \u2013 causing cancer cells to multiply.<\/p>\n

IDRX-42 is a tyrosine kinase inhibitor (TKI). TKIs stop or slow down KIT activity and the resulting growth of cancer cells. Other TKIs are used for GIST but may not work against all KIT<\/i> mutations. IDRX-42 is designed to cover a broader range of KIT<\/i> mutations.” text_color_type=”uncode-palette” text_color_solid=”#ff0000″]What is IDRX-42?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”172011″ subheading=”As with all medicines, there is the possibility of side-effects, which are unwanted or unintended effects of a medicine. Talk to the study doctor for more information on possible side-effects. Your health will be closely monitored throughout the entire trial. Tell the study doctor if you notice any side-effects or changes in your health.”]Are there any side-effects from the study drugs?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”114741″ subheading=”Yes, the study doctor will let you know which study treatment you are receiving.<\/p>\n

If I am assigned to receive sunitinib, will I have a chance of receiving IDRX-42? If you are taking sunitinib and your cancer worsens, you may be able to change to IDRX-42.” text_color_type=”uncode-palette” text_color_solid=”#ff0000″]Will I know if I am receiving IDRX-42 or sunitinib?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=””][vc_column_inner width=”1\/3″][vc_custom_heading text_color=”color-681992″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”123134″ text_color_type=”uncode-palette”]StrateGIST 3 questions[\/vc_custom_heading][vc_empty_space empty_h=”2″][\/vc_column_inner][vc_column_inner width=”2\/3″][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”699296″ subheading=”You will be in the trial for up to 5.5 years. As with any clinical trial, you may stop participation at any time for any reason or no reason. IDRX, Inc. does not have any plans to provide IDRX-42 or any other study drugs or procedures to you after the end of the trial or if you have discontinued or have been withdrawn from the trial.”]How long will I be in the trial?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”127156″ subheading=”If you qualify for the trial, you will be randomly placed into a group to receive either IDRX-42 or sunitinib, a treatment approved in some countries for the type of GIST being studied.”]What study treatment will I receive?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”514493″ subheading=”IDRX-42 comes as tablets that you will take by mouth with water (with or without food). You will take IDRX-42 once a day as directed by the study doctor. You will keep taking IDRX-42 for as long as your cancer is not getting worse and you are tolerating treatment.”]How do I take IDRX-42?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”355188″ subheading=”Sunitinib comes as capsules that you will take by mouth with water (with or without food). Sunitinib is taken once a day for 28 days at a time, followed by a 14-day break, unless otherwise instructed. You will keep taking sunitinib for as long as your cancer is not getting worse and you are tolerating treatment. If your cancer worsens while taking sunitinib, you may be able to change to IDRX-42.”]How do I take sunitinib?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”700478″]What clinical trial sites are participating in StrateGIST 3?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=”480045″ css=”.vc_custom_1732655988927{margin-top: 10px !important;}”]Click here<\/a> for a list of participating sites and to find a location near you.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=”100″ override_padding=”yes” h_padding=”2″ top_padding=”7″ bottom_padding=”7″ back_color=”color-xsdn” back_image=”112276″ back_attachment=”fixed” overlay_alpha=”50″ gutter_size=”0″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ top_divider=”step_1_2″ medium_visibility=”yes” changer_back_color=”yes” uncode_shortcode_id=”111832″ back_color_type=”uncode-palette” row_name=”questions”][vc_column column_width_percent=”100″ gutter_size=”5″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”166430″][vc_row_inner limit_content=””][vc_column_inner width=”1\/3″][vc_custom_heading text_color=”color-681992″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”384218″ text_color_type=”uncode-palette”]General questions[\/vc_custom_heading][vc_empty_space empty_h=”2″][\/vc_column_inner][vc_column_inner width=”2\/3″][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”204481″ subheading=”No benefits are guaranteed, however, your health will be monitored continuously throughout the StrateGIST 3 Trial. Even if you do not directly benefit from participating in the trial, any information collected may help researchers learn more about the study drug IDRX-42 (GSK6042981) and about treating other adults with GIST in the future.”]What are the benefits of participating in StrateGIST 3?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”104022″ subheading=”As with all medicines, there is a risk for side effects from the study drugs. However, your safety is our top priority. Your health will be closely monitored during the entire study.”]Are their risks to participating in the trial?[\/vc_custom_heading][vc_custom_heading 1=”biopharmaceutical” 2=”company” 3=”IDRx,” 4=”Inc.” 5=”is” 6=”sponsoring” 7=”the” 8=”clinical” 9=”trial.” 10=”They” 11=”will” 12=”pay” 13=”the” 14=”study” 15=”doctor” 16=”and” 17=”site” 18=”staff” 19=”to” 20=”run” 21=”this” 22=”trial.” 23=”To” 24=”learn” 25=”more” 26=”about” 27=”IDRx,” 28=”visit” 29=”” 30=”href=““https:\/\/www.idrx.com““>www.idrx.com” 31=”.“” heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”657637″]Who is sponsoring the StrateGIST 3 clinical trial?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=”779402″ css=”.vc_custom_1755617742215{margin-top: 10px !important;}”]The global biopharma company GSK is sponsoring the StrateGIST 3 clinical trial. They will pay the study doctors and site staff to run the trial. To learn more about GSK, visit <\/span>www.gsk.com<\/a>.[\/vc_column_text][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”500375″ subheading=”The study treatment, site visits, and study-related tests will be paid for by the clinical trial sponsor GSK. If you are eligible, you may have trial-related tests and visits provided at no additional cost. In the US, participants may be required to provide insurance for certain procedures as part of the trial.”]Will it cost me anything to be in the trial?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”430406″ subheading=”Participation in a clinical trial is voluntary. If you decide to join and then change your mind, you can leave the trial at any time. Leaving the trial will not affect your regular medical care.”]What if I decide to join the trial and then change my mind?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=””][vc_column_inner width=”1\/3″][vc_custom_heading text_color=”color-681992″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”115706″ text_color_type=”uncode-palette”]Study drug questions[\/vc_custom_heading][vc_empty_space empty_h=”2″][\/vc_column_inner][vc_column_inner width=”2\/3″][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”159505″ subheading=”GIST is frequently caused by changes, or mutations, in a gene for a normal cell protein called KIT. These mutations lead to over-activation of KIT \u2013 like a switch stuck in the on position \u2013 causing cancer cells to multiply.<\/p>\n

IDRX-42 (GSK6042981) is a tyrosine kinase inhibitor (TKI). TKIs stop or slow down KIT activity and the resulting growth of cancer cells. Other TKIs are used for GIST but may not work against all KIT mutations. IDRX-42 (GSK6042981) is designed to cover a broader range of KIT mutations.” text_color_type=”uncode-palette” text_color_solid=”#ff0000″]What is IDRX-42 (GSK6042981)[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”172011″ subheading=”As with all medicines, there is the possibility of side-effects, which are unwanted or unintended effects of a medicine. Talk to the study doctor for more information on possible side-effects. Your health will be closely monitored throughout the entire trial. Tell the study doctor if you notice any side-effects or changes in your health.”]Are there any side-effects from the study drugs?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”970928″ subheading=”Yes, the study doctor will let you know which study treatment you are receiving.”]Will I know if I am receiving IDRX-42 (GSK6042981)
\nor sunitinib?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=””][vc_column_inner width=”1\/3″][vc_custom_heading text_color=”color-681992″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”123134″ text_color_type=”uncode-palette”]StrateGIST 3 questions[\/vc_custom_heading][vc_empty_space empty_h=”2″][\/vc_column_inner][vc_column_inner width=”2\/3″][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”759072″ subheading=”You will be in the trial for up to five years. As with any clinical trial, you may stop participation at any time for any reason or no reason. GSK does not have any plans to provide IDRX-42 (GSK6042981) or any other study drugs or procedures to you after the end of the trial or if you have discontinued or have been withdrawn from the trial.”]How long will I be in the trial?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”124602″ subheading=”If you qualify for the trial, you will be randomly placed into a group to receive either IDRX-42 (GSK6042981) or sunitinib, a treatment approved in some countries for the type of GIST being studied. At the end of the study, if you qualify, GSK may provide access to IDRX-42 (GSK6042981) via a separate access programme depending on local regulations.”]What study treatment will I receive?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”191460″ subheading=”IDRX-42 (GSK6042981) comes as tablets that you will take by mouth with water (with or without food). You will take IDRX-42 (GSK6042981) once a day as directed by the study doctor. You will keep taking IDRX-42 (GSK6042981) for as long as your cancer is not getting worse and you are tolerating treatment.”]How do I take IDRX-42 (GSK6042981)?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”152983″ subheading=”Sunitinib comes as capsules that you will take by mouth with water (with or without food). Sunitinib is taken once a day for 28 days at a time, followed by a 14-day break, unless otherwise instructed. You will keep taking sunitinib for as long as your cancer is not getting worse and you are tolerating treatment.”]How do I take sunitinib?[\/vc_custom_heading][vc_custom_heading heading_semantic=”h3″ text_size=”” sub_reduced=”yes” text_align=”text-left” text_serif=”yes” uncode_shortcode_id=”700478″]What clinical trial sites are participating in StrateGIST 3?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=”480045″ css=”.vc_custom_1732655988927{margin-top: 10px !important;}”]Click here<\/a> for a list of participating sites and to find a location near you.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row row_height_percent=”100″ back_color=”color-138503″ back_image=”112255″ back_repeat=”no-repeat” back_attachment=”scroll” back_position=”center center” parallax=”yes” overlay_alpha=”50″ gutter_size=”4″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ enable_bottom_divider=”default” bottom_divider_inv=”tilt” shape_bottom_invert=”yes” shape_bottom_h_use_pixel=”” shape_bottom_height=”100″ shape_bottom_color=”color-xsdn” […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-139998","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/en-gb\/wp-json\/wp\/v2\/pages\/139998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/en-gb\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/en-gb\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/en-gb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/en-gb\/wp-json\/wp\/v2\/comments?post=139998"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/en-gb\/wp-json\/wp\/v2\/pages\/139998\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/en-gb\/wp-json\/wp\/v2\/media?parent=139998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}